TRXE-009-1, an investigational small molecule, significantly inhibits tumour growth and extends survival in vivo. Eleanor I. Ager1, Dhanalakshmi Sivanandhan2, Ram Sudheer Adluri3, Alex Stevenson4, Eleanor Eiffe1, Andrew

First Page		Document Content
B-Raf inhibitor Dabrafenib Pyrimidines Sulfonamides Thiazoles		TRXE-009-1, an investigational small molecule, significantly inhibits tumour growth and extends survival in vivo. Eleanor I. Ager1, Dhanalakshmi Sivanandhan2, Ram Sudheer Adluri3, Alex Stevenson4, Eleanor Eiffe1, Andrew Add to Reading List Source URL: www.novogen.com Download Document from Source Website File Size: 730,40 KB Share Document on Facebook

	A conserved protonation-dependent switch controls drug binding in the Abl kinase Yibing Shana, Markus A. Seeligerb, Michael P. Eastwooda, Filipp Frankb, Huafeng Xua, Morten Ø. Jensena, Ron O. Drora, John Kuriyanb,1, and DocID: 1rq9v - View Document
	Best Maid Snickerdoodle 1 DocID: 1roug - View Document
	imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib DocID: 1rdbp - View Document
	1 DIRECTIONS FOR USE RESTRAINTS DO NOT apply by air, except on potatoes DocID: 1qZHf - View Document
	Sr.No Activity Animal Model Extract Dose (mg/kg) Result Remarks 1. Immuno-modulatory Action Ochratoxin A induced immune suppression 1 Ethanolic (Whole Plant) 100 Peptide IL-1 and TNF normalised Immuno- stimulation DocID: 1qPNj - View Document